Jami Earnest, PharmD, BCPP, is affiliated with Supernus Pharmaceuticals, Inc., Rockville, Maryland. Earnest has published on the pharmacokinetics of viloxazine extended-release capsules in breast milk and the use of viloxazine ER in adults with attention-deficit/hyperactivity disorder (ADHD) and comorbid depression and anxiety symptoms. Research topics include anxiety, ADHD, major depressive disorder, psychopharmacology, and women's health. Collaborators frequently include Greg W. Mattingly, Himanshu Upadhyaya, Ilmiya Yarullina, Jonathan Rubin, and Lenard A. Adler.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
